Market News & Trends
Allegro Ophthalmics Announces Positive Topline Results From Phase II Trial
Allegro Ophthalmics, LLC, recently announced that the Phase II clinical trial of Luminate® (ALG-1001) in patients with vitreomacular traction (VMT) or vitreomacular adhesion (VMA) met…
Genentech's Investigational Immunotherapy Atezolizumab Shrank Tumors in Pivotal Study
Genentech, a member of the Roche Group recently announced that in the IMvigor 210 study, the investigational cancer immunotherapy atezolizumab (MPDL3280A; anti-PDL1) shrank tumors (objective…
CiMaas & PharmaCell BV Enter Collaborative Agreement
CiMaas BV, a company developing cellular immunotherapy for cancer, and PharmaCell BV, a leading Contract Manufacturing Organization for Cellular Therapies and Regenerative Medicine in Europe,…
EyeGate Signs Licensing Agreement With Valeant Pharmaceuticals
Eyegate Pharmaceuticals, Inc., a specialty pharmaceutical company that focuses on developing and commercializing therapeutics and drug delivery systems for treating diseases of the eye, today…
Foster Polymer Copolymer for Medical Mandrels & Release Films
Foster Polymer Distribution, a business unit of Foster Corporation specializing in the distribution of medical polymers and additives, announces their official partnership with Mitsui Chemicals…
Celgene & Juno Announce 10-Year Collaboration to Advance Potentially Groundbreaking Immunotherapies
Celgene Corporation (Nasdaq:CELG) and Juno Therapeutics, Inc. (Nasdaq:JUNO) announced today a global collaboration for the development and commercialization of immunotherapies. The two companies will leverage…
Leti & Eight Partners in BIOCAPAN Project Working On Diabetes Treatment to Replace Injections
An international research consortium coordinated by CEA-Leti announced the launch of BIOCAPAN, a research project funded by the European Commission aiming at developing an innovative…
Transdermal Specialties Announces Success of Insulin Patch Clinical Trial
In June, 2015 TSI began the HPT-6B.3 clinical trial with 12 type-2 diabetic volunteers, both male and female subjects, who were subject to a 24…
Lonza to Expand Availability of 3D Cell Culture System
Lonza has announced that it has reached an exclusive agreement with TAP Biosystems, part of the Stedim Biotech Group, to distribute the company’s RAFT™ (Real…
DPT Enhances Flexibility & Efficiencies at San Antonio Facility
DPT Laboratories, a contract development and manufacturing organization (CDMO) specializing in semi-solids and liquids, has implemented a new order execution strategy that will enhance operations…
Catalent Biologics Adds New Technology Platform
Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, today announced that…
Ludwig Cancer Research & University of Oxford Launch Cancer Immunotherapy Spinout
Isis Innovation, the University of Oxford’s technology commercialisation company, and Ludwig Cancer Research are proud to announce the launch of a new spinout company, iOx…
Exostar's Identity Hubs - Making Security a Business Enabler Throughout the Drug Development Process
With a price tag north of $1B and a duration in the neighborhood of a decade, the drug development process costs too much and takes…
Capsugel Unveils New Facility; Significantly Expands Capability
Capsugel recently announced it has completed construction of a new pharmaceutical spray-dried dispersion (SDD) commercial manufacturing facility at its site in Bend, OR. The completion…
Avexxin Completes Phase I/IIA Study; Achieves PoC In Man With Topical Formulation
Avexxin's lead compound AVX001 in a topical formulation has shown Proof-of-Concept in man in an ascending dose Phase I/IIa study encompassing 26 patients suffering from…
ImmunoCellular Therapeutics Establishes Agreement With Novella Clinical
ImmunoCellular Therapeutics, Ltd. recently announced the establishment of an agreement with Novella Clinical to conduct the Phase III registration trial of ICT-107 in patients with…
Rock Creek Pharmaceuticals Reports Human Proof-of-Principle Study
Rock Creek Pharmaceuticals, Inc., recently announced the results of a human proof-of- principle study with anatabine citrate, the company's lead compound. Results from the study…
AAA Signs Distribution Agreement With FUJIFILM RI Pharma
Advanced Accelerator Applications S.A. (AAA) recently announced it has entered into a distribution agreement for Lutathera in Japan with FUJIFILM RI Pharma, Co., LTD (FRI).…
Palatin Technologies Completes $30-Million Financing
Palatin Technologies, Inc. recently announced it has closed on a private placement of Series E warrants to purchase 21,917,808 shares of its common stock and…
“Biomaterial of the Future” Nanocellulose to Send Market Booming with 42.8% CAGR
Nanocellulose (NC) is quickly becoming commercially available worldwide, and the production capacity is increasing exponentially. BCC Research reveals in its new report, Cellulose Nanoparticles: Processing,…
